1. Ailments in Covid-19 Trials Raise Questions About Vaccine Method  Bloomberg
  2. Washington University starts clinical trial for drugs to build immunity for COVID-19 patients  KMOV St. Louis
  3. Better Coronavirus Stock: AstraZeneca or Johnson & Johnson  The Motley Fool
  4. View Full Coverage on Google News

Bloomberg - Are you a robot?

These two pharma heavyweights are among the many players racing to get a COVID-19 vaccine approved.These two pharma heavyweights are among the many players racing to get a COVID-19 vaccine approved.

Better Coronavirus Stock: AstraZeneca or Johnson & Johnson | The Motley Fool